Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ARIAD Pharmaceuticals CEO Interviewed by StreetSideInvestor.


Business Editors

BLOOMINGTON, Ind IND Investigational new drug Therapeutics A status assigned by the FDA to a drug before allowing its use in humans, exempting it from premarketing approval requirements so that experimental clinical trials may be conducted. See Phase 1.2, 3 studies, Sponsorship. .--(BUSINESS WIRE)--Sept. 22, 2000

Dr. Harvey Harvey, city (1990 pop. 29,771), Cook co., NE Ill., a suburb S of Chicago; inc. 1895. Its manufactures include steel castings, metal products, chemicals, machinery, and electronic equipment. Harvey has an oil research center. The city was founded by Turlington W.  J. Berger, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of ARIAD ARIAD Allison Research Index of Art and Design  Pharmaceuticals (Nasdaq:ARIA) is featured as one of the premier executives interviewed on StreetSideInvestor's Executives' Corner, which can be accessed at www.streetsideinvestor.com. StreetSideInvestor's innovative Executive's Corner interviews executives using questions submitted by investors and individuals. To submit your questions for future interviews please visit www.streetsideinvestor.com

Chairman and CEO Dr. Berger discusses ARIAD's future outlook and recent company products and technology developments. The interview is available in print format free of charge at www.StreetSideInvestor.com, and you may sign up to receive future Executives' Corners via e-mail by registering for free at http://www.streetsideinvestor.com/register/newuser.php3?english

About ARIAD Pharmaceuticals:

ARIAD Pharmaceuticals, Inc. (www.ariad.com) is a leader in the discovery and development of gene therapy, cell therapy, stem cell therapy stem cell therapy Cell therapy Molecular medicine A technology in which a person's own cells–eg, neuronal stem cells are triggered to revert to their primitive embryonic form, then redifferentiate into mature cells of various organs  and protein therapy products featuring dose-dependent regulation by small-molecule drugs, as well as small-molecule inhibitors of signal transduction Signal transduction

The transmission of molecular signals from a cell's exterior to its interior. Molecular signals are transmitted between cells by the secretion of hormones and other chemical factors, which are then picked up by different cells.
.

About StreetSideInvestor, Inc.

StreetSideInvestor, Inc. is a leading financial content provider committed to providing in-depth cutting edge research to the investing public. The company's English site, located at http://www.streetsideinvestor.com, offers commentary from an experienced team of financial journalists and provides innovative features such as the Insider Wire, StreetSide Insider, Executives' Corner, and Head-to-Head.

StreetSideInvestor Inc. offers investors the opportunity to submit questions for executives featured on Executives' Corner. To see the current schedule of interviews please visit http://www.streetsideinvestor.com/askexec/nologin_exec.php3

To view previous Executives' Corner please visit http://www.streetsideinvestor.com/getcolumn.php3?exec

If you would like to receive Executives' Corner in your mailbox A simulated mailbox in the computer that holds e-mail messages. Mailboxes are stored on disk as a file of messages, a database of messages or as an individual file for each message. The standard mailboxes are usually In, Out, Trash and Junk (Spam).  please register for free at http://www.streetsideinvestor.com/register/newuser.php3?english

For more information on StreetSideInvestor Inc. visit http://www.streetsideinvestor.com/ or you can email us at feedback@streetsideinvestor.com
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Sep 22, 2000
Words:311
Previous Article:Harris & Harris Group Increases Cash Position.
Next Article:KMC Telecom Charity Golf Tournament On September 25th to Benefit Community Help Centers.
Topics:



Related Articles
ARIAD Chief Executive to Appear On CNBC's "Squawk Box" on March 3, 2000 at Approximately 9:00 AM EST.
Immunex CFO Interviewed by StreetSideInvestor.
ISIS Pharmaceuticals CEO Interviewed by StreetSideInvestor.
ARIAD Chief Executive Interviewed Today By The Wall Street Reporter Magazine.
ARIAD Product Pipeline and Recent Financings Featured On CEOcast Investor Program.
Cell Pathways CEO Interviewed by StreetSideInvestor.
ARIAD's Recent Scientific Advances Featured Today by Wall Street Reporter Magazine.
Epitope CEO Interviewed by StreetSideInvestor.
ARIAD Gene Regulation Technologies And Genomics Developments Featured On CEOcast Investor Program.
SCLN CEO Interviewed by StreetSideInvestor.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles